French Observatory of Familial Hypercholesterolemia in Cardiology (FH Care)
|ClinicalTrials.gov Identifier: NCT02013713|
Recruitment Status : Suspended (Lack of enrollment)
First Posted : December 17, 2013
Last Update Posted : November 24, 2017
The Family Hypercholesterolemia remains poorly diagnosed disease with an outlet sometimes suboptimal care. However, the Family Hypercholesterolemia exposes patients concerned at increased cardiovascular risk.
The frequency of familial hypercholesterolemia in cardiologic is little studied and remains unknown, and there is little data on the profile of patients, diagnostic methods and management.
- Establish a monitoring patients with hypercholesterolemia Family cardiology in France
- Characterize the Family hypercholesterolemia in cardiology, including assessing the frequency of the most severe forms, which are at higher cardiovascular risk.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||French Observatory of Familial Hypercholesterolemia in Cardiology|
|Study Start Date :||November 2014|
|Estimated Primary Completion Date :||December 2022|
|Estimated Study Completion Date :||December 2023|
|Family Hypercholesterolemia in cardiology|
- Frequency of the Family Hypercholesterolemia in cardiology [ Time Frame: 1 day ]Number of Family Hypercholesterolemia among patients with LDL-C> 1.9g / l without hypoglycemic treatment or> 1.6g / l in lipid-lowering therapy
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02013713
|European Hospital Georges Pompidou|
|Paris, France, 75015|